epcoritamab-CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for epcoritamab-CAR T cells, covering 2025-03-27 to 2025-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Epcoritamab-CAR T Cells for Large B-cell Lymphomas [Phase 2]